Advanced Search
Contact | Corporate | Help

Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract

Sponsors:
  • Dartmouth-Hitchcock Medical Center
  • Genentech
  • Ligand Pharmaceuticals
Phases:
  • Phase I
IndicationsAcronym:
  • Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bexarotene (Targretin®)
  • Drug: Erlotinib (Tarceva™)
Enrollment:
24

Additional information about NCT01116622.


SourceSolution © 2008-2012